Who Owns Mereo BioPharma Group Stock?
NASDAQ: MREOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 0.3483 -0.46%
Ownership breakdown
- Held by institutions
- 35.47%
- Held by insiders
- 0.75%
- Institutional holders
- 64
- Institutions 35.5%
- Insiders 0.7%
- Public and other 63.8%
Who owns Mereo BioPharma Group stock?
Institutional investors own about 35.5% of Mereo BioPharma Group's shares, spread across 64 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.75% of MREO.
The largest institutional holders are Rubric Capital Management LP (9.59%), 683 Capital Management LLC (7.38%) and Bank of America Corporation (5.13%). Together, the top 10 institutions control 32.9% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their MREO positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MREO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Rubric Capital Management LP | 15.31M | 9.59% | 0.0% |
| 683 Capital Management LLC | 11.78M | 7.38% | -1.9% |
| Bank of America Corporation | 8.20M | 5.13% | 0.0% |
| Defilade Capital Management, L.P. | 7.56M | 4.73% | 0.0% |
| Newtyn Management, Llc | 3.00M | 1.88% | -57.6% |
| Tejara Capital Ltd | 2.04M | 1.28% | 0.0% |
| UBS Group AG | 1.45M | 0.91% | -2.9% |
| Two Sigma Investments, LP | 1.32M | 0.83% | +602.3% |
| EcoR1 Capital, LLC | 1.00M | 0.63% | -92.5% |
| Jane Street Group, LLC | 774.94K | 0.49% | +453.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MREO
| Fund | Shares | % Held |
|---|---|---|
| SPDR INDEX SHARES Fd.S-State Street SPDR S&P Intl Small Cap ETF | 135.46K | 0.08% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 14.50K | 0.01% |
Frequently asked questions
Who is the largest shareholder of Mereo BioPharma Group?
Rubric Capital Management LP is the largest institutional shareholder of MREO, owning 9.59% of shares outstanding (15.31M shares) as of its latest 13F filing.
What percentage of Mereo BioPharma Group is owned by institutions?
Institutions own about 35.5% of MREO shares and 35.7% of the public float.
How much of Mereo BioPharma Group do insiders own?
Insiders, such as officers and directors, own about 0.75% of MREO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.